What is TBPH's gross margin?

Theravance (TBPH) has a gross margin of 92% and a net margin of -28%.

What is TBPH's P/E ratio?

TBPH's P/E ratio is 7.3 with ROE of 49%.

Where can I see TBPH's full financials?

See Theravance (TBPH) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Theravance (TBPH) Financials — Revenue, Earnings, Cash Flow

$16.37

+0.03 (+0.18%)

Weekly Expected Move ±3.0%

$15 $16 $16 $17 $17

NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 41 · $843.9M mcap · 48M float · 1.24% daily turnover · Short 61% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

📊 Key Metrics

TTM

$110M

Revenue

+68.2% YoY

$115M

Net Income

+296.4% YoY

$269M

Free Cash Flow

+732.4% YoY

91.9%

Gross Margin

-46.9%

Op. Margin

-27.9%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE48.5%

ROA27.3%

ROIC0.1%

Valuation

P/E7.3

P/B2.9

EV/EBITDA74.2

Leverage

Debt/Equity0.25

Current Ratio10.93

Interest Cov.2.3x

Quality Scores

Piotroski F8/9

Altman Z1.36

Beneish M-4.26